Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Astria Therapeutics Inc
ATXSCurrent price
10.09 USD
-1.44 USD (-12.49%)
Last closed
10.61 USD
Company
www.astriatx.com
ISIN
US04635X1028
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
666 947 008 USD
Yield for 12 month
+124.72 %
1Y
3Y
5Y
10Y
15Y
ATXS
Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in Phase 1b/2 clinical trials for the treatment of hereditary angioedema. The company is also developing STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, an immune disorder associated with loss of skin barrier function and itching. The company was formerly known as Catabasis Pharmaceuticals, Inc. and changed its name to Astria Therapeutics, Inc. in September 2021. Astria Therapeutics, Inc. was incorporated in 2008 and is headquartered in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
25.14 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures ATXS
1 year
3 years
5 years
10 years
EBITDA
-32 380 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.04 %
PEG Ratio
–
Return On Equity TTM
-34.06 %
Wall Street Target Price
25.14 USD
Revenue TTM
–
Book Value
4.58 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.38 USD
Diluted Eps TTM
-2.38 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ATXS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ATXS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:6
Payout Ratio
–
Last Split Date
20.08.2021
Dividend Date
31.12.2018
Stock Valuation ATXS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-7.5695
Price Book MRQ
2.6492
Financials ATXS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ATXS
For 52 weeks
4.26 USD
16.9 USD
50 Day MA
11.5 USD
Shares Short Prior Month
3 468 262
200 Day MA
11.44 USD
Short Ratio
7.85
Shares Short
3 494 164
Short Percent
6.43 %
BeatStart